ZA944950B - Protein purification - Google Patents

Protein purification

Info

Publication number
ZA944950B
ZA944950B ZA944950A ZA944950A ZA944950B ZA 944950 B ZA944950 B ZA 944950B ZA 944950 A ZA944950 A ZA 944950A ZA 944950 A ZA944950 A ZA 944950A ZA 944950 B ZA944950 B ZA 944950B
Authority
ZA
South Africa
Prior art keywords
pct
protein purification
sec
date
pub
Prior art date
Application number
ZA944950A
Other languages
English (en)
Inventor
Thomas M Smith
Gail Folena-Wasserman
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Publication of ZA944950B publication Critical patent/ZA944950B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70596—Molecules with a "CD"-designation not provided for elsewhere

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ZA944950A 1993-07-09 1994-07-08 Protein purification ZA944950B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US9035193A 1993-07-09 1993-07-09

Publications (1)

Publication Number Publication Date
ZA944950B true ZA944950B (en) 1995-02-22

Family

ID=22222418

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA944950A ZA944950B (en) 1993-07-09 1994-07-08 Protein purification

Country Status (11)

Country Link
US (1) US5840858A (xx)
EP (1) EP0812200B1 (xx)
JP (1) JPH08512323A (xx)
CN (1) CN1130353A (xx)
AT (1) ATE213639T1 (xx)
AU (1) AU688778B2 (xx)
CA (1) CA2166805A1 (xx)
DE (1) DE69430016D1 (xx)
NZ (1) NZ269375A (xx)
WO (1) WO1995001797A1 (xx)
ZA (1) ZA944950B (xx)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6395888B1 (en) * 1996-02-01 2002-05-28 Gilead Sciences, Inc. High affinity nucleic acid ligands of complement system proteins
FR2737730B1 (fr) * 1995-08-10 1997-09-05 Pasteur Merieux Serums Vacc Procede de purification de virus par chromatographie
AU4672297A (en) * 1996-10-07 1998-05-05 Edge Biosystems, Inc. Targeted addition of soluble polymers to recombinant proteins
US5932102A (en) * 1998-01-12 1999-08-03 Schering Corporation Immobilized metal, affinity chromatography
US6479300B1 (en) * 1999-03-15 2002-11-12 Millipore Corporation Metal loaded ligand bound membranes for metal ion affinity chromatography
US20050026270A1 (en) * 2001-06-20 2005-02-03 University Of Maryland Stable subtilin and methods of manufacture
KR20050074997A (ko) * 2002-11-15 2005-07-19 아레스 트레이딩 에스.에이. Ｉｍａｃ를 이용한 ｔｎｆ-결합 단백질의 정제 방법
US6913695B2 (en) * 2003-07-08 2005-07-05 Bayer Healthcare Llc Sanitization of chromatographic media
CN1283792C (zh) * 2003-11-14 2006-11-08 余伟明 生物大分子组分相分离法
US7803931B2 (en) 2004-02-12 2010-09-28 Archemix Corp. Aptamer therapeutics useful in the treatment of complement-related disorders
US7169425B2 (en) * 2004-09-17 2007-01-30 Solae, Llc Size exclusion chromatography process for the preparation of an improved soy protein-containing composition
US20060062889A1 (en) * 2004-09-17 2006-03-23 Solae, Llc. Soy protein-containing composition
JP4668643B2 (ja) * 2005-02-23 2011-04-13 オリンパスメディカルシステムズ株式会社 内視鏡装置
EP1738763A1 (en) 2005-06-30 2007-01-03 AVANT Immunotherapeutics, Inc. Use of complement inhibitory proteins to treat spinal cord injury
JP5249582B2 (ja) * 2005-08-26 2013-07-31 独立行政法人科学技術振興機構 インプリントポリマーおよびその利用
US20070148721A1 (en) * 2005-12-28 2007-06-28 Agilent Technologies, Inc. Compositions, methods, systems, and kits for affinity purification
SI2596807T1 (sl) 2006-03-08 2016-03-31 Archemix Llc Komplement vezavni aptameri in sredstva proti C5, uporabni pri zdravljenju očesnih motenj
CA2708836A1 (en) * 2007-12-17 2009-06-25 Affisink Biotechnology Ltd. Methods for purifying or depleting molecules or cells of interest
BR112012002574A2 (pt) * 2009-08-06 2020-11-03 Genentech, Inc. método para aprimorar a remoção de vírus na purificação de proteínas
CN102234332B (zh) * 2010-04-26 2014-12-17 浙江海正药业股份有限公司 一种重组人血白蛋白及其融合蛋白的分离纯化工艺
JP5635682B2 (ja) * 2010-05-19 2014-12-03 エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ 疎水性相互作用クロマトグラフィー法
CN103237557A (zh) 2010-09-15 2013-08-07 赛尔戴克斯治疗公司 用可溶性I型补体受体(sCR1)治疗慢性肾病
CA2815237C (en) 2010-10-27 2018-10-09 Celldex Therapeutics, Inc. Method of improving transplant function using soluble complement receptor type i (scr1)
CN103344171B (zh) * 2013-06-28 2017-11-21 山东新华医疗器械股份有限公司 多方向位置移动检测装置
JP6851109B2 (ja) * 2016-06-16 2021-03-31 Jsr株式会社 抗体を精製する方法及び担体を洗浄する方法
CN109633053B (zh) * 2018-12-19 2021-04-30 杭州奕安济世生物药业有限公司 细胞培养物蛋白质表达量和蛋白质聚集体量的检测方法
WO2023240322A1 (en) * 2022-06-17 2023-12-21 CSL Innovation Pty Ltd Purification of soluble complement receptor and variants thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5256642A (en) * 1988-04-01 1993-10-26 The Johns Hopkins University Compositions of soluble complement receptor 1 (CR1) and a thrombolytic agent, and the methods of use thereof
CA2006684C (en) * 1988-12-30 1996-12-17 Charles T. Esmon Monoclonal antibody against protein c
US5169936A (en) * 1989-04-14 1992-12-08 Biogen, Inc. Protein purification on immobilized metal affinity resins effected by elution using a weak ligand
US5252216A (en) * 1992-03-24 1993-10-12 Smithkline Beecham Corporation Protein purification

Also Published As

Publication number Publication date
JPH08512323A (ja) 1996-12-24
EP0812200A4 (en) 1998-06-10
EP0812200A1 (en) 1997-12-17
AU688778B2 (en) 1998-03-19
EP0812200B1 (en) 2002-02-27
US5840858A (en) 1998-11-24
DE69430016D1 (de) 2002-04-04
NZ269375A (en) 1997-11-24
ATE213639T1 (de) 2002-03-15
CA2166805A1 (en) 1995-01-19
WO1995001797A1 (en) 1995-01-19
CN1130353A (zh) 1996-09-04
AU7322994A (en) 1995-02-06

Similar Documents

Publication Publication Date Title
ZA944950B (en) Protein purification
GR3034332T3 (en) Protein purification.
ZA951372B (en) Antibody purification
IL132249A0 (en) Type ii tgf-beta receptor/immunoglobulin constant region fusion proteins
MY113497A (en) Peptides and compounds that bind to a receptor
BG102690A (en) Il-8 receptor antagonists
PT832200E (pt) Novos métodos de purificação de factor ix
ZA939621B (en) Protein named component B
MY129293A (en) The use of mmp-13 selective inhibitors for the treatment of osteoarthristis and other mmp-mediated disorders
EP0713495A4 (en) METHODS FOR IMPROVING THE BIOACTIVITY OF CHIMIOKINES
CA2220447A1 (en) Novel fusion protein recovery and purification methods
IL122606A (en) (S)-hydroxa-nitrile-lyase
ZA966315B (en) Method for the purification of proteins
BG104373A (en) Polymorphous forms of dofetilide
BG102937A (en) Zona pelucida proteins as contraceptives
ATE328088T1 (de) Transketolase-verwandtes protein
ES2152982T3 (es) Analogos de la difluoroestatona.
SE9303822D0 (sv) Method for purification